Is adenomyosis associated with menorrhagia?
article
OA: closed
CC0
⤵ 87 in-corpus citations
AI-generated summary
No association was found between adenomyosis and menorrhagia, but greater severity of adenomyosis on ultrasound correlated with increased menstrual blood loss.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Is the presence of adenomyosis associated with menorrhagia? SUMMARY ANSWER: There was no significant association between adenomyosis and menorrhagia, but there was a significant positive correlation between the severity of adenomyosis on ultrasound and the amount of menstrual loss estimated using pictorial blood loss assessment charts. WHAT IS KNOWN ALREADY: There is no consensus in the literature with regards to the association between adenomyosis and menorrhagia. Previous studies have been limited to retrospective studies of highly selected populations which mainly included women who underwent hysterectomy. There are no large prospective studies evaluating the association between adenomyosis and menorrhagia, either in the general population of women or in a general gynaecology clinic setting. STUDY DESIGN, SIZE, DURATION: This was a prospective observational study set in the general gynaecology clinic of a university teaching hospital between January 2009 and January 2010. PARTICIPANTS/MATERIALS, SETTING, METHODS: There were 714 consecutive premenopausal women who attended the clinic and underwent structured clinical and transvaginal ultrasound examination in accordance with the study protocol. Morphological features of adenomyosis were systematically recorded on ultrasound scan. Menorrhagia was determined subjectively by direct questioning and objectively by completion of pictorial blood loss analysis charts. MAIN RESULTS AND THE ROLE OF CHANCE: A diagnosis of adenomyosis was made in 157/714 women [22.0% (95% CI: 19.1-25.2%)]. Multivariable analysis showed significant associations between submucous fibroids [OR 5.60 (95% CI: 2.69-11.6)], any fibroids [OR 1.53 (95% CI: 0.91-2.58)] and endometrial polyps [OR 2.81 (95% CI: 1.15-11.7)] and menorrhagia. There were also significant associations between increasing gravidity and BMI and menorrhagia (P < 0.01). There was no significant association between adenomyosis and menorrhagia in the study population, when adenomyosis was assessed as a binary outcome. When severity of adenomyosis was assessed by counting the number of morphological features of adenomyosis in each woman, we found a significant 22% increase in menstrual loss for each additional feature of adenomyosis [OR 1.21 (95% CI: 1.04-1.40)]. LIMITATIONS, REASONS FOR CAUTION: A classification of severity of adenomyosis based on the number of ultrasound features present is a novel concept that should be prospectively evaluated in different populations. WIDER IMPLICATIONS OF THE FINDINGS: A better understanding of the relationship between adenomyosis and menorrhagia can help improve counselling of women regarding the significance of this common condition and facilitate future studies assessing the effectiveness of different conservative treatments protocols. STUDY FUNDING/COMPETING INTEREST(S): The authors have no competing interests. The study was not supported by an external grant.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- Adenomyosis: A reappraisal of symptomatology via openalex
- Adenomyosis uteri: an update via openalex
- How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex
- Prevalence and risk factors of adenomyosis at hysterectomy via openalex
- Risk factors for adenomyosis via openalex
- The elusive adenomyosis of the uterus via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- Transvaginal sonography in the diagnosis of adenomyosis: which findings are most accurate? via openalex
- W1982489497 via openalex
- W2083329737 via openalex
- W2087847123 via openalex
- W2113991585 via openalex
- W1965039757 via openalex
- W1861209549 via openalex
- W2128212773 via openalex
- W1574798160 via openalex
- W2031107525 via openalex
- W4230036251 via openalex
- W2042374015 via openalex
Cited by (50)
- 3D and 4D Ultrasound of Adenomyosis 2026
- Hormonal therapy versus hysterectomy in the management of symptomatic adenomyosis 2025
- The Landscape and Regulatory Mechanisms of Aberrant Alternative Splicing Events in Adenomyosis 2025
- Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 2025
- Adenomyosis: A Call for Awareness, Early Detection and Effective Treatment Strategies 2024
- Adenomyosis—A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Internal and external adenomyosis phenotypes: ultrasound features and association with clinical outcomes 2024
- Correlation between sonographic classification and the efficacy of microwave ablation for adenomyosis 2024
- Ultrasound Elastography in Benign Gynecology: A Scoping Review 2024
- Pulmonary embolism after diagnostic curettage in patient with adenomyosis and hysteromyoma: A case report and brief review of literature 2023
- Adenomyosis and uterine stiffness: what is the chicken? Which is the egg? 2023
- Evaluation of Deeply Infiltrating Endometriosis by Preoperative Magnetic Resonance Imaging in Patients with Adenomyosis 2023
- Contemporary evaluation of women and girls with abnormal uterine bleeding: <scp>FIGO</scp> Systems 1 and 2 2023
- Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis 2023
- Are lower levels of apoptosis and autophagy behind adenomyotic lesion survival? 2023
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- Low-dose letrozole – an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix 2023
- Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis 2023
- Understanding Ultrasound Features that Predict Symptom Severity in Patients with Adenomyosis: a Systematic Review 2023
- Adenomiosis: diagnóstico 2023
- Directive clinique no 437 : Diagnostic et prise en charge de l’adénomyose 2023
- Classification of Uterine Adenomyosis 2022
- Classifications of Adenomyosis and Correlation of Phenotypes in Imaging and Histopathology to Clinical Outcomes: a Review 2022
- Adenomiosis and sterility. Revue of the reproductive events after operative treatment and extracorporal fertilization 2022
- Noninvasive Diagnosis of Adenomyosis: Ultrasonography 2022
- The Prevalence and Clinical Impact of Adenomyosis in Pregnancy-Related Hysterectomy 2022
- Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis 2022
- Melatonin improves pregnancy outcomes in adenomyosis mice by restoring endometrial receptivity via NF-κB/apoptosis signaling 2022
- Noninvasive Diagnosis of Adenomyosis: Ultrasonography 2022
- Adenomyosis; Diagnosis, Clinical Findings and Current Approaches to Treatment 2022
- Association between the occurrence of adenomyosis and the clinical outcomes of vaginal repair of cesarean section scar defects: an observational study 2022
- Adenomyosis in a postmenopausal woman: A rare entity 2022
- Melatonin improves endometrial receptivity of adenomyosis mice via the NF-κB signaling pathway 2022
- Relationship between magnetic resonance imaging‐based classification of adenomyosis and disease severity 2021
- Influence of nodular and severe forms of diffuse adenomyosis on reproductive function: a review of reproductive outcomes of surgical interventions and IVF 2021
- The myometrial‐cervical ratio (MCR): Assessing the diagnostic accuracy of a novel ultrasound measurement in the diagnosis of adenomyosis 2021
- Endometriosis increases the rate of spontaneous early miscarriage in women who have adenomyosis lesions 2021
- Clinicopathological characteristics and imaging findings to identify adenomyosis‐related symptoms 2021
- Abnormal uterine bleeding: Terminology, FIGO classification and management 2021
- Immune cells and Notch1 signaling appear to drive the epithelial to mesenchymal transition in the development of adenomyosis in mice 2021
- The Clinical Features and Diagnosis of Adenomyosis 2021
- Sonographic and clinical features of adenomyosis in women in "early" (18-35) and "advanced" (>35) reproductive ages 2021
- Epidemiology of Adenomyosis 2020
- A Systematic Review of Adenomyosis: It Is Time to Reassess What We Thought We Knew about the Disease 2020
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis 2020
- Exploring the challenges for a new classification of adenomyosis 2020
- Diagnosing adenomyosis: an integrated clinical and imaging approach 2020
- Association between the Occurrence of Adenomyosis and the Clinical Outcomes of Vaginal Repair of Cesarean Scar Defects: An Observational Cohort Study 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:40.923139+00:00
License: CC0
· commercial use OK